Qihuang Needle Therapy to Treat Limb Dysfunction in Ischemic Stroke: A Randomized Controlled Trial
Medical Acupuncture · 23.06.2026
DOI: 10.1177/19336586261457079 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Medical Acupuncture, online erschienen am 23.06.2026. Verfasst von Jingjing Zhan und 3 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Qingdao 2023 Medical and Health Research Guidance Project.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Acupuncture treatment of stroke has been widely accepted in China. However, due to the diversity of acupuncture treatment methods, there is no recognized simple and effective acupuncture method, which affects the wider application of acupuncture in the treatment of ischemic stroke. The Qihuang needle at a few acupoints without needle retention has a unique effect but lacks a randomized control trial on stroke published in PubMed.
Objective
This study was to observe the efficacy of Qihuang needle therapy in treating limb dysfunction in ischemic stroke.
Methods
From January 2023 to August 2024, 60 patients with limb dysfunction after the ischemic stroke were selected from Qingdao West Coast The Third Hospital and randomized into the two groups (control and intervention groups, i.e., standard care plus acupuncture), with 30 candidates in each group. The control group was routinely treated with neurological nursing and medication, and the Qihuang needle group as the intervention group with acupuncture at 3–4 acupoints from Jianqian (Extra), Shousanli (LI10), Daling (PC7), Chize (LU5), Xiyangguan (GB33), Feiyang (BL 58), and Weizhong (BL40), performed on the side of limb dysfunction, based on the status of the patient. After all treatments, the National Institute of Health Stroke Scale (NIHSS) and Barthel Index (BI) were compared between the two groups. Then, the 90-day modified Rankin Scale (mRS) of 0–2 was statistically analyzed.
Results
After all the Qihuang needle treatments, NIHSS, and BI were significantly better than those in the control group ( p < 0.05). The number of 90-day mRS of 0–2 of the Qihuang needle group was higher than that of the control group (60% vs. 45%, p < 0.01) without obvious adverse effects.
Conclusion
The treatment of limb dysfunction in ischemic stroke patients by Qihuang needle therapy significantly improved limb function, increased BI, and decreased NIHSS. Better functional recovery at 90 days was higher than that of the control group.
Förderung
- Qingdao 2023 Medical and Health Research Guidance Project
Zitieren
APA
Zhan, J., Zang, F., Wang, L., & Gao, H. (2026). Qihuang Needle Therapy to Treat Limb Dysfunction in Ischemic Stroke: A Randomized Controlled Trial. Medical Acupuncture. https://doi.org/10.1177/19336586261457079
Vancouver
Zhan J, Zang F, Wang L, Gao H. Qihuang Needle Therapy to Treat Limb Dysfunction in Ischemic Stroke: A Randomized Controlled Trial. Medical Acupuncture. 2026. doi:10.1177/19336586261457079
BibTeX
@article{Zhan2026,
author = {Zhan, Jingjing and Zang, Fengling and Wang, Lijie and Gao, Huanmin},
title = {Qihuang Needle Therapy to Treat Limb Dysfunction in Ischemic Stroke: A Randomized Controlled Trial},
journal = {Medical Acupuncture},
year = {2026},
doi = {10.1177/19336586261457079}
}
EUVIMED